Evaluation of the diagnostic value of a three-miRNA panel in prostate cancer: a discovery and validation study
Abstract Background PSA is widely used in prostate cancer screening. However, false-positive PSA results can lead to misdiagnosis and wrong puncture biopsy, while false-negative PSA results can result in missed diagnosis and delayed treatment. There is an urgent need to find convenient, economical a...
Saved in:
| Main Authors: | Xutai Li, Chen Sun, Zhenjian Ge, Yingqi Li, Huimei Zhou, Yutong Wu, Shengjie Lin, Pengwu Zhang, Xionghui Wu, Yongqing Lai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-04-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02382-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A panel of three serum microRNAs as a potential diagnostic biomarker for renal cell carcinoma
by: Shengjie Lin, et al.
Published: (2025-05-01) -
Evaluation of specific lncRNAs, miRNAs, and mRNAs in different groups of prostate cancer
by: Gelareh Vahabzadeh, et al.
Published: (2025-01-01) -
Recent progress in miRNA biogenesis and decay
by: Xavier Bofill-De Ros, et al.
Published: (2024-12-01) -
The miRNAs 203a/210‐3p/5001‐5p regulate the androgen/androgen receptor/YAP‐induced migration in prostate cancer cells
by: Chieh Huo, et al.
Published: (2024-08-01) -
Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis
by: Shweta Singh, et al.
Published: (2025-08-01)